Cytochrome Enzymes and Glycoproteins: What You need to Know

Why are Cytochrome P450 and P-Glycoproteins so important?

Cytochrome (CYP) enzymes are responsible for the metabolism of over 70% of drugs in clinical use. They determine how much of the drugs that we absorb make it to the site of action. Glycoprotein (P-gp) transporters and CYP enzymes have significant overlap of substrates. Because of this they are often considered together.

CYP/P-gp interactions are prevalent throughout pharmacology and very significant to your clinical practice. Let me show you how.

Cytochrome P450

CYP are a group of enzymes that clear foreign substances, including drugs, from the body. Simply put CYP enzymes convert drugs from their active forms to forms that can be eliminated via urine or feces. They act mainly in the liver, metabolizing drugs primarily by oxidation processes.

P-Glycoproteins

P Glycoproteins (P-gp) are transporter proteins found in cell membranes. Simply put, PGPs pump foreign substances, including drugs, out of cells. This is known as transmembrane efflux hence P-gp transporters are commonly referred to as efflux pumps. They are located in the esophagus, stomach, and small and large intestines.

Mechanism of CYP/P-gp Drug Interactions

Many of the drugs currently in clinical practice interact with CYP enzymes and PGP transporters in some way. Those drugs are either substrates, inhibitors or inducers of the CYP/P-gp proteins.

Mechanisms of Inhibition and Induction

PGP and CYP enzymes are commonly considered together because their induction and inhibition have mirroring effects. Inhibition of both will decrease drug clearance, induction of both will increase drug clearance. PGP and CYP enzymes also share many inducers and inhibitors.

Illustration showing the correlation between cytochrome P450 enzymes and P glycoproteins

.

Cytochrome P450 and P-Glycoproteins Explained

Clinically Significant CYP/P-gp Drugs

The degree to which CYP/P-gp drugs can induce or inhibit those proteins vary from weak to strong. CYP proteins also exist as different isozymes: 1A2, 2CP, 2C19, 2D6, 2E1 and 3A4.

Below is a list of clinically significant drugs that act as either inhibitors, inducers or substrates of CYP/P-gp proteins. CYP 3A4 has by far the most prevalent and significant interactions.

For a comprehensive list of CYP/P-gp inducers, inhibitors and substrates:

Michalets, E.L. (1998), Update: Clinically Significant Cytochrome P-450 Drug Interactions. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 18: 84-112. 

Below is an abbreviated list that is based on my experience. These are the ones you want to keep in the back of your mind. If you see any of these, it should trigger a need for close investigation for drug interactions.

Chart showing clinically significant cytochrome P450 and P glycoprotein inhibitors and inducers

If this unit has been helpful I would love to hear from you! Leave a question or comment below.

Subscribe

Subscribe to get the latest study unit in your inbox.

The information on this website is intended to be used solely for educational and informational purposes. While the content may be about specific medical and health care issues, it is not a substitute for or replacement of personalized medical advice and is not intended to be used as the sole basis for making individualized medical or health-related decisions.

Published by pharmHERcology

Residency Trained, Board Certified Clinical Pharmacist with 10+ years of hospital based practice. I am here to help you succeed in all aspects of practice, from state exams. specialty certifications and every day patient care.

5 thoughts on “Cytochrome Enzymes and Glycoproteins: What You need to Know

Leave a Reply

Discover more from pharmHERcology

Subscribe now to keep reading and get access to the full archive.

Continue reading